PORTFOLIO STRATEGY
Population & Disease Analysis to Support Clinical Trial Design
SITUATION
A top global biopharmaceutical company was interested in conducting inclusive clinical trial research (US and global) and sought a deeper understanding of population-specific differences in epidemiology, molecular drivers, clinical treatment pathways, and outcomes across multiple therapeutic indications.
OUR ROLE
Working with a cross-functional group, we designed a data package to define key inclusion criteria most relevant for the planned trials. Leveraging comprehensive literature review and analysis, parsing and prioritizing thousands of results, we identified relevant papers and opinion leaders for each indication. We also identified ethnic disparities, culminating in indication-specific data packages to inform potential clinical trial strategy and design.
IMPACT
Our findings regarding race and ethnic disparities within the target therapeutic areas were integral in defining patient recruitment strategies and identifying target indications for future clinical research. The methodology our team helped develop was presented at the American Association for Cancer Research (AACR) Annual Meeting and used as template for other organizations to follow.
